Showing results (51-60 of 268) with videos related to
Sort By:
Pageof 27
Drugs|October 1, 1992
Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorderD Murdoch, D McTavishTransactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1980
On the longevity of Schistosoma mansoni in man on St. Lucia, West IndiesM J Goddard, P JordanRegulatory Toxicology and Pharmacology : RTP|December 1, 1983
The power and interpretation of the carcinogenicity bioassayD B Clayson, D Krewski, I C MunroAmerican Journal of Epidemiology|August 3, 1999
Increased effects of smoking and obesity on asthma among female Canadians: the National Population Health Survey, 1994-1995Y Chen, R Dales, D Krewski, et al.Annals of the New York Academy of Sciences|February 17, 2000
Estimates of the proportions of carcinogens and anticarcinogens in bioassays conducted by the U.S. National Toxicology Program. Application of a new meta-analytic approachK S Crump, D Krewski, C Van LandinghamCancer Letters|April 15, 1993
Physiological pharmacokinetics and cancer risk assessmentM E Andersen, D Krewski, J R WitheyEnvironmental Health Perspectives|January 5, 1999
Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology ProgramK S Crump, D Krewski, C Van LandinghamThe European Respiratory Journal|November 27, 2002
Sex-related interactive effect of smoking and household pets on asthma incidenceY Chen, R Dales, M Tang, et al.Regulatory Toxicology and Pharmacology : RTP|February 3, 1999
Procedures for calculating benchmark doses for health risk assessmentD Gaylor, L Ryan, D Krewski, et al.Journal of Toxicology and Environmental Health. Part B, Critical Reviews|November 28, 2024
Review of non-invasive biomarkers as a tool for exposure characterization in human health risk assessmentsN Shilnikova, F Momoli, N Karyakina, et al.Pageof 27